72117 De novo belatacept does not reduce skin cancer incidence and burden in renal transplant recipients
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB137
DOI: 10.1016/j.jaad.2026.04.554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Darartu Gamada und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gamada, D., Fan, E., Motavaf, M., Chopra, S., Liu, B., Green, C., & Whitley, M. (2026). 72117 De novo belatacept does not reduce skin cancer incidence and burden in renal transplant recipients. Journal of the American Academy of Dermatology, 95(1), AB137. https://doi.org/10.1016/j.jaad.2026.04.554
Vancouver
Gamada D, Fan E, Motavaf M, Chopra S, Liu B, Green C, et al. 72117 De novo belatacept does not reduce skin cancer incidence and burden in renal transplant recipients. Journal of the American Academy of Dermatology. 2026;95(1):AB137. doi:10.1016/j.jaad.2026.04.554
BibTeX
@article{Gamada2026,
author = {Gamada, Darartu and Fan, Elizabeth and Motavaf, Mateen and Chopra, Sakshi and Liu, Beiyu and Green, Cynthia and Whitley, Melodi},
title = {72117 De novo belatacept does not reduce skin cancer incidence and burden in renal transplant recipients},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB137},
doi = {10.1016/j.jaad.2026.04.554}
}
EUVIMED